Serdexmethylphenidate
| SDX | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 499.5 g/mol [1] |
| Predicted LogP | 2.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C25H29N3O8 [1] |
| IUPAC name | (2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoate [1] |
| SMILES | COC(=O)[C@@H]([C@H]1CCCCN1C(=O)OC[N+]2=CC=CC(=C2)C(=O)N[C@@H](CO)C(=O)[O-])C3=CC=CC=C3 [1] |
| InChI | InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/t19-,20+,21+/m0/s1 [1] |
| InChIKey | UBZPNQRBUOBBLN-PWRODBHTSA-N [1] |
Serdexmethylphenidate (also known as KP-415 inner salt, Unii-0h8kz470dw, KP484, KP-484, Pyridinium, 3-((((1S)-1-carboxy-2-hydroxyethyl)amino)carbonyl)-1-(((((2R)-2-((1R)-2-methoxy-2-oxo-1-phenylethyl)-1-piperidinyl)carbonyl)oxy)methyl)-, serdexmetilfenidato, Azstarys, N-(1-((((2r)-2-((1r)-2-methoxy-2-oxo-1-phenylethyl)piperidine-1-carbonyl)oxy)methyl)pyridin-1-ium-3-carbonyl)-l-serinate, (2S)-3-hydroxy-2-((1-(((2R)-2-((1R)-2-methoxy-2-oxo-1-phenylethyl)piperidine-1-carbonyl)oxymethyl)pyridin-1-ium-3-carbonyl)amino)propanoate or serdexmethylphenidatum) is a
Chemistry
Stereochemistry []
Serdexmethylphenidate is a absolute mixture.
Subjective effects []
Legal status []
- United States: Serdexmethylphenidate is a Schedule I under the "Controlled Substances Act (CSA)".[3]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 134823895, Serdexmethylphenidate. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/134823895
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Serdexmethylphenidate. UNII: 0H8KZ470DW. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/0H8KZ470DW
Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV. June 24, 2022. Accessed May 8, 2026. https://www.federalregister.gov/documents/2022/06/24/2022-13538/schedules-of-controlled-substances-placement-of-serdexmethylphenidate-in-schedule-iv